Abstract
Objectives: Neoadjuvant therapy is a promising alternative in patients with locally advanced bronchogenic carcinoma. This may be associated with an increased risk of morbidity and mortality especially after bronchial sleeve resection. We compared our results after induction therapy of patients with typical lung resection and bronchial sleeve resection.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
